State Street Corp raised its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 1.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 102,216,308 shares of the company’s stock after purchasing an additional 965,461 shares during the period. State Street Corp owned 4.40% of Procter & Gamble worth $14,988,999,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PG. Evolution Wealth Management Inc. lifted its stake in Procter & Gamble by 1,315.4% in the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after buying an additional 171 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $26,000. Basso Capital Management L.P. purchased a new stake in Procter & Gamble in the 4th quarter valued at $28,000. Montgomery Financial Services LLC acquired a new stake in Procter & Gamble during the 2nd quarter worth $28,000. Finally, Paladin Partners LLC purchased a new position in Procter & Gamble during the 2nd quarter worth $29,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity
In related news, CAO Matthew W. Janzaruk sold 359 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer directly owned 1,271 shares of the company’s stock, valued at $184,600.04. This trade represents a 22.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Susan Whaley sold 2,238 shares of Procter & Gamble stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $321,802.02. Following the transaction, the insider directly owned 26,989 shares of the company’s stock, valued at approximately $3,880,748.31. This represents a 7.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 6,627 shares of company stock worth $953,417. Company insiders own 0.23% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. During the same quarter last year, the firm posted $1.48 EPS. The business’s revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, sell-side analysts expect that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Friday, July 24th were issued a $1.0885 dividend. The ex-dividend date of this dividend was Friday, July 24th. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is 65.71%.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: PG continues to attract income-oriented investors as a Dividend King. Analysts and long-term investing research highlight the potential benefits of dividend growth, while Procter & Gamble’s broad portfolio and brand strength provide resilience during periods of higher household costs. 2 Rock-Solid Dividend Stocks to Buy in September Even as Oil Surges Past $100 Per Barrel
- Positive Sentiment: A comparison with Colgate-Palmolive emphasizes PG’s portfolio breadth, category leadership, premium products and digital investment, supporting the view that it remains well positioned to defend market share in consumer staples. PG vs. CL: Which Consumer Staples Giant Has Stronger Market Position?
- Positive Sentiment: A historical feature on the low-cost electric toothbrush concept that ultimately generated a reported $475 million outcome underscores the value of consumer innovation associated with PG’s oral-care business, although it is not a new financial announcement. John Osher Built a $475 Million Toothbrush by Starting at 80 Cents While Rivals Started at $79
- Neutral Sentiment: PG was included in a broader Zacks analyst roundup focused on innovation and operational performance, but the article provides no material new company-specific guidance. The Zacks Analyst Blog Highlights Procter & Gamble, Sandisk, Analog Devices, Monarch Cement and SUNation Energy
- Negative Sentiment: The main risk is that pricing may not offset elusive volume growth. PG reportedly faces an approximately $1.4 billion after-tax earnings headwind in fiscal 2027 from higher costs, foreign-exchange pressure and other factors, creating uncertainty around margin and earnings growth. Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?
Analysts Set New Price Targets
A number of brokerages have recently commented on PG. Citigroup reduced their target price on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a report on Thursday, July 30th. HSBC reissued a “hold” rating and set a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Argus downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research report on Wednesday, June 24th. Finally, BMO Capital Markets lifted their target price on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a research note on Monday, June 29th. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $161.55.
View Our Latest Stock Report on PG
Procter & Gamble Profile
Procter & Gamble Company is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio spans beauty, grooming, health care, fabric and home care, and family care products.
The company’s brands include Tide, Ariel, Downy, Dawn, Febreze, Bounty, Charmin, Pampers, Gillette, Oral-B, Crest, Head & Shoulders, Olay and Pantene. These products are sold through retailers, e-commerce platforms and other distribution channels.
Procter & Gamble was founded in Cincinnati in 1837 by William Procter and James Gamble.
Further Reading
- Five stocks we like better than Procter & Gamble
- IonQ’s AI Breakthrough Looks Big—But Can It Drive Revenue?
- Broadcom CEO Holds $350B Outlook Strong Amid Calls to Slow Froniter AI Development
- Microsoft’s 8% Dividend Hike: Confidence Signal or Distraction From Capex Math?
- Paramount Skydance Clears a Major Warner Bros. Discovery Hurdle—Here’s What Comes Next
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
